Open access · OA
via OpenAlex
Telomere Length in Prospective and Retrospective Cancer Case-Control Studies
Karen A. Pooley, Manjinder Singh Sandhu, Jonathan P. Tyrer, Mitul Shah, Kristy E. Driver, Robert Luben, Sheila Anne Bingham, Bruce A.J. Ponder, Paul D.P. Pharoah, Kay‐Tee Khaw, Douglas F. Easton, Alison M. Dunning
Cancer Research · 2010 · ▲ 162 citations
Abstract
Previous studies have reported that shorter mean telomere(definition) length in lymphocytes was associated with increased susceptibility to common diseases of aging, and may be predictive of cancer risk. However, most analyses have examined retrospectively collected case-control studies. Mean telomere length was measured using high-throughput quantitative real-time PCR. Blood for DNA extraction was collected after cancer diagnosis in the East Anglian SEARCH Breast (2,243 cases and 2,181 controls) and SEARCH Colorectal (2,249 cases and 2,161 controls) studies. Prospective case-control studies were conducted for breast cancer (199 cases) and colorectal cancer (185 cases), nested within the EPIC-Norfolk cohort. Blood was collected at least 6 months prior to diagnosis, and was matched to DNA from two cancer-free controls per case. In the retrospective SEARCH studies, the age-adjusted odds ratios for shortest (Q4) versus longest (Q1) quartile of mean telomere length was 15.5 [95% confidence intervals (CI), 11.6-20.8; p-het = 5.7 x 10(-75)], with a "per quartile" P-trend = 2.1 x 10(-80) for breast cancer; and 2.14 (95% CI, 1.77-2.59; p-het = 7.3 x 10(-15)), with a per quartile P-trend = 1.8 x 10(-13) for colorectal cancer. In the prospective EPIC study, the comparable odds ratios (Q4 versus Q1) were 1.58 (95% CI, 0.75-3.31; p-het = 0.23) for breast cancer and 1.13 (95% CI, 0.54-2.36; p-het = 0.75) for colorectal cancer risk. Mean telomere length was shorter in retrospectively collected cases than in controls but the equivalent association was markedly weaker in the prospective studies. This suggests that telomere shortening largely occurs after diagnosis, and therefore, might not be of value in cancer prediction.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1158/0008-5472.can-09-4595
- Canonical
- link ↗
- Fetched
- 2026-09-25 MST
Cite this
APA
Pooley, K.A., Sandhu, M.S., Tyrer, J.P., Shah, M., Driver, K.E., Luben, R., Bingham, S.A., Ponder, B.A., Pharoah, P.D., Khaw, K., Easton, D.F., & Dunning, A.M. (2010). Telomere Length in Prospective and Retrospective Cancer Case-Control Studies. <em>Cancer Research</em>. https://doi.org/10.1158/0008-5472.can-09-4595
Vancouver
Pooley KA, Sandhu MS, Tyrer JP, Shah M, Driver KE, Luben R, et al. Telomere Length in Prospective and Retrospective Cancer Case-Control Studies. Cancer Research. 2010. doi:10.1158/0008-5472.can-09-4595.
BibTeX
@article{karen2010Telome,
title = {Telomere Length in Prospective and Retrospective Cancer Case-Control Studies},
author = {Karen A. Pooley and Manjinder Singh Sandhu and Jonathan P. Tyrer and Mitul Shah and Kristy E. Driver and Robert Luben and Sheila Anne Bingham and Bruce A.J. Ponder and Paul D.P. Pharoah and Kay‐Tee Khaw and Douglas F. Easton and Alison M. Dunning},
journal = {Cancer Research},
year = {2010},
doi = {10.1158/0008-5472.can-09-4595},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Breast Cancer Research 2022
Open access · CC-BY
Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: a pooled analysis of four prospective studies
Research Square 2022
Preprint · CC-BY
Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: A pooled analysis of four prospective studies
International Journal of Cancer 2017
Open access · OA
DNA methylation‐based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies
Scientific Reports 2026
Open access · CC-BY
Leukocyte telomere attrition following radiotherapy in prostate cancer: a prospective study
Scientific reports 2026
Open access · OA
Leukocyte telomere attrition following radiotherapy in prostate cancer: a prospective study.
Cancer Medicine 2024
Open access · CC-BY